146 related articles for article (PubMed ID: 36847377)
41. Inappropriate P-cadherin expression in the mouse mammary epithelium is compatible with normal mammary gland function.
Radice GL; Sauer CL; Kostetskii I; Peralta Soler A; Knudsen KA
Differentiation; 2003 Aug; 71(6):361-73. PubMed ID: 12919105
[TBL] [Abstract][Full Text] [Related]
42. A method of producing genetically manipulated mouse mammary gland.
Tagaya H; Ishikawa K; Hosokawa Y; Kobayashi S; Ueoka Y; Shimada M; Ohashi Y; Mikami H; Yamamoto M; Ihara T; Kumazawa K; Sugihara K; Goshima N; Watanabe S; Semba K
Breast Cancer Res; 2019 Jan; 21(1):1. PubMed ID: 30611295
[TBL] [Abstract][Full Text] [Related]
43. Intraductally administered pegylated liposomal doxorubicin reduces mammary stem cell function in the mammary gland but in the long term, induces malignant tumors.
Chun YS; Yoshida T; Mori T; Huso DL; Zhang Z; Stearns V; Perkins B; Jones RJ; Sukumar S
Breast Cancer Res Treat; 2012 Aug; 135(1):201-8. PubMed ID: 22752247
[TBL] [Abstract][Full Text] [Related]
44. Methods to study primary tumor cells and residual tumor cells in mouse models of oncogene dependence.
Botta C; Darini C; Darrasse-Jèze G; Podsypanina K
Methods Mol Biol; 2015; 1267():381-94. PubMed ID: 25636480
[TBL] [Abstract][Full Text] [Related]
45. Ductal tree ablation by local delivery of ethanol prevents tumor formation in an aggressive mouse model of breast cancer.
Kenyon E; Westerhuis JJ; Volk M; Hix J; Chakravarty S; Claucherty E; Zaluzec E; Ramsey L; Madaj Z; Hostetter G; Eagleson B; Shapiro E; Moore A; Sempere LF
Breast Cancer Res; 2019 Nov; 21(1):129. PubMed ID: 31779648
[TBL] [Abstract][Full Text] [Related]
46. The transformation of primary and established mouse mammary epithelial cells by p21-ras is concentration dependent.
Redmond SM; Reichmann E; Müller RG; Friis RR; Groner B; Hynes NE
Oncogene; 1988 Mar; 2(3):259-65. PubMed ID: 3127778
[TBL] [Abstract][Full Text] [Related]
47. Chemical effects in transgenic mice bearing oncogenes expressed in mammary tissue.
Tennant RW; Rao GN; Russfield A; Seilkop S; Braun AG
Carcinogenesis; 1993 Jan; 14(1):29-35. PubMed ID: 8093862
[TBL] [Abstract][Full Text] [Related]
48. Alteration of morphogenesis by the v-myc oncogene in transplants of mammary gland.
Edwards PA; Ward JL; Bradbury JM
Oncogene; 1988 Apr; 2(4):407-12. PubMed ID: 3283657
[TBL] [Abstract][Full Text] [Related]
49. Deletion of Tip30 leads to rapid immortalization of murine mammary epithelial cells and ductal hyperplasia in the mammary gland.
Pecha J; Ankrapp D; Jiang C; Tang W; Hoshino I; Bruck K; Wagner KU; Xiao H
Oncogene; 2007 Nov; 26(53):7423-31. PubMed ID: 17533366
[TBL] [Abstract][Full Text] [Related]
50. Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers.
Andrechek ER; Laing MA; Girgis-Gabardo AA; Siegel PM; Cardiff RD; Muller WJ
Cancer Res; 2003 Aug; 63(16):4920-6. PubMed ID: 12941816
[TBL] [Abstract][Full Text] [Related]
51. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
Amundadottir LT; Leder P
Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
[TBL] [Abstract][Full Text] [Related]
52. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
[TBL] [Abstract][Full Text] [Related]
53. Krt6a-positive mammary epithelial progenitors are not at increased vulnerability to tumorigenesis initiated by ErbB2.
Holloway KR; Sinha VC; Toneff MJ; Bu W; Hilsenbeck SG; Li Y
PLoS One; 2015; 10(1):e0117239. PubMed ID: 25635772
[TBL] [Abstract][Full Text] [Related]
54. The comparative pathology of human and mouse mammary glands.
Cardiff RD; Wellings SR
J Mammary Gland Biol Neoplasia; 1999 Jan; 4(1):105-22. PubMed ID: 10219910
[TBL] [Abstract][Full Text] [Related]
55. Protein-tyrosine phosphatase epsilon. An isoform specifically expressed in mouse mammary tumors initiated by v-Ha-ras OR neu.
Elson A; Leder P
J Biol Chem; 1995 Nov; 270(44):26116-22. PubMed ID: 7592814
[TBL] [Abstract][Full Text] [Related]
56. Adenovirus vaccination against neu oncogene exerts long-term protection from tumorigenesis in BALB/neuT transgenic mice.
Gallo P; Dharmapuri S; Nuzzo M; Maldini D; Cipriani B; Forni G; Monaci P
Int J Cancer; 2007 Feb; 120(3):574-84. PubMed ID: 17096348
[TBL] [Abstract][Full Text] [Related]
57. Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice.
Huang S; Li Y; Chen Y; Podsypanina K; Chamorro M; Olshen AB; Desai KV; Tann A; Petersen D; Green JE; Varmus HE
Genome Biol; 2005; 6(10):R84. PubMed ID: 16207355
[TBL] [Abstract][Full Text] [Related]
58. Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia.
Hoshino A; Yee CJ; Campbell M; Woltjer RL; Townsend RL; van der Meer R; Shyr Y; Holt JT; Moses HL; Jensen RA
Int J Biol Sci; 2007 Apr; 3(5):281-91. PubMed ID: 17505536
[TBL] [Abstract][Full Text] [Related]
59. The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.
Wellberg EA; Johnson S; Finlay-Schultz J; Lewis AS; Terrell KL; Sartorius CA; Abel ED; Muller WJ; Anderson SM
Breast Cancer Res; 2016 Dec; 18(1):131. PubMed ID: 27998284
[TBL] [Abstract][Full Text] [Related]
60. Mammary glands reconstituted with Neu/ErbB2 transformed HC11 cells provide a novel orthotopic tumor model for testing anti-cancer agents.
Brandt R; Wong AM; Hynes NE
Oncogene; 2001 Sep; 20(39):5459-65. PubMed ID: 11571643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
